G6PD deficiency in malaria endemic areas of Nepal

BACKGROUND: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is currently a threat to malaria elimination due to risk of primaquine-induced haemolysis in G6PD deficient individuals. The World Health Organization (WHO) recommends G6PD screening before providing primaquine as a radical treatment ag...

Descripción completa

Detalles Bibliográficos
Autores principales: Marasini, Baburam, Lal, Bibek Kumar, Thapa, Suman, Awasthi, Kiran Raj, Bajracharya, Bijay, Khanal, Pratik, Neupane, Sanjeev, Jha, Shambhu Nath, Acharya, Sanjaya, Iama, Smriti, Koirala, Madan, Koirala, Dinesh, Bhandari, Suresh, Mahato, Ram Kumar, Chaudhary, Arun, Ghimire, Pramin, Magar, Rahachan Gharti, Bhattarai, Rajan Kumar, Gornsawun, Gornpan, Penpitchaporn, Pimsupah, Bancone, Germana, Acharya, Bhim Prasad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425560/
https://www.ncbi.nlm.nih.gov/pubmed/32787970
http://dx.doi.org/10.1186/s12936-020-03359-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425560/
https://www.ncbi.nlm.nih.gov/pubmed/32787970
http://dx.doi.org/10.1186/s12936-020-03359-6

Ejemplares similares